Pharmacy Report Archives - Page 103 of 136 - Becker's Hospital Review

Best insurers for Medicare drug coverage, per US News | Hospitals denied full court review in 340B lawsuit | NIH to test J&J, AbbVie, Bristol Myers Squibb drugs as COVID-19 treatments | FDA advisory panel to discuss COVID-19 vaccine approval process

October 20, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA advisory panel to publicly discuss COVID-19 vaccine approval process Full story 2. Hospitals denied full court review in lawsuit over 340B cuts Full story 3. NIH to…

CVS to hire 15K employees for flu season | Pfizer vaccine trial becomes first in US to enroll children | Hospitals return $2.3B in federal COVID-19 aid | Walgreens, CVS partner with HHS to administer free COVID-19 vaccines

October 19, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Walgreens, CVS will offer free COVID-19 vaccines at long-term care facilities Full story 2. Renown Health names new VP of pharmacy Full story 3. CVS to hire 15,000…

Eli Lilly drug trial halted due to clinical status of several participants | Walgreens Q4 results boosted by higher pharmacy sales | $200 Medicare drug cards won't arrive before Election Day | Ohio judge postpones opioid trials against pharmacies

October 15, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Walgreens 4th-quarter sales at retail pharmacies up 3.6% Full story 2. Eli Lilly antibody drug trial halted due to clinical status of several participants, NIH says Full…

7 health systems form specialty pharmacy alliance | Eli Lilly halts COVID-19 antibody drug trial over safety concern | The 2021 Medicare plans with 5 stars | HHS fund shields drugmakers from vaccine-related liabilities

October 14, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 7 health systems form specialty pharmacy alliance Full story 2. Eli Lilly halts COVID-19 antibody drug trial over safety concern Full story 3. Virginia community health center rebrands,…

J&J pauses vaccine trial over participant's illness | AstraZeneca, US ink $486M deal for COVID-19 antibody drug | 171 testing sites shut for failing to meet US standards | 3 more drugmakers recall metformin due to carcinogen

October 13, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. J&J pauses COVID-19 vaccine trial over participant's 'unexplained illness' Full story 2. AstraZeneca, US ink $486M deal for COVID-19 antibody drug Full story 3. 171 COVID-19 testing sites…

Mallinckrodt files for bankruptcy | Operation Warp Speed czar: Vaccine approval likely to be sought around Thanksgiving | 6 hospitals opening pharmacies | Remdesivir cuts COVID-19 recovery time by 5 days, final study data says

October 12, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mallinckrodt files for Chapter 11 bankruptcy Full story 2. Trump pushes quick FDA approval of COVID-19 antibody treatments Full story 3. Operation Warp Speed czar: Vaccine approval likely…

Regeneron applies for EUA for COVID-19 antibody cocktail | M Health Fairview to close 5 pharmacies | Dexamethasone price spikes 137% | Insulin costs up to 10x more in US than other wealthy countries

October 8, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Regeneron seeks emergency approval of COVID-19 treatment taken by President Trump Full story 2. M Health Fairview to close 5 pharmacies, cites COVID-19 losses Full story 3. Dexamethasone…

Former HHS vaccine official resigns months after whistleblower complaint | White House endorses FDA's vaccine guidelines | Miss. pharmacy owners charged in $18M healthcare fraud scheme | Eli Lilly submits EUA for COVID-19 antibody drug

October 7, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Former vaccine official resigns from HHS months after demotion, whistleblower complaint Full story 2. White House reverses course, endorses FDA's COVID-19 vaccine authorization guidelines Full story 3. Mississippi…

White House slows FDA's COVID-19 vaccine guidelines | 8 drugs Trump has been given for COVID-19 | Dartmouth-Hitchcock opens new pharmacy | Europe investigates reports of kidney injury in remdesivir patients

October 6, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. White House ignoring, unlikely to approve FDA's new COVID-19 vaccine guidelines Full story 2. 8 drugs Trump has been given for his COVID-19 treatment Full story 3.…

Trump prescribed dexamethasone for COVID-19 | FDA expands probe of AstraZeneca's vaccine | Bristol Myers Squibb to acquire heart drugmaker for $13B | University of Oxford to test AbbVie's Humira as COVID-19 treatment

October 5, 2020 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. What we know about President Trump's treatment, hospitalization + 5 more COVID-19 updates Full story 2. FDA expands probe of AstraZeneca's COVID-19 vaccine; US trial still…